FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2736720011> ?p ?o ?g. }

• W2736720011 endingPage "4410" @default.
• W2736720011 startingPage "4403" @default.
• W2736720011 abstract "Several studies have demonstrated that approximately one-half of patients with chronic myeloid leukemia (CML) who receive treatment with tyrosine kinase inhibitors (TKIs) and achieve and maintain a deep molecular response (DMR) are able to successfully discontinue therapy. In patients who have a molecular relapse, a DMR is rapidly regained upon treatment re-initiation.The authors report the results from RE-STIM, a French observational, multicenter study that evaluated treatment-free remission (TFR) in 70 patients who re-attempted TKI discontinuation after a first unsuccessful attempt. After the second TKI discontinuation attempt, the trigger for treatment re-introduction was the loss of a major molecular response in all patients.The median follow-up was 38.3 months (range, 4.7-117 months), and 45 patients (64.3%) lost a major molecular response after a median time off therapy of 5.3 months (range, 2-42 months). TFR rates at 12, 24, and 36 months were 48% (95% confidence interval [CI], 37.6%-61.5%), 42% (95% CI, 31.5%-55.4%), and 35% (95% CI, 24.4%-49.4%), respectively. No progression toward advanced-phase CML occurred, and no efficacy issue was observed upon TKI re-introduction. In univariate analysis, the speed of molecular relapse after the first TKI discontinuation attempt was the only factor significantly associated with outcome. The TFR rate at 24 months was 72% (95% CI, 48.8%-100%) in patients who remained in DMR within the first 3 months after the first TKI discontinuation and 36% (95% CI, 25.8%-51.3%) for others.This study is the first to demonstrate that a second TKI discontinuation attempt is safe and that a first failed attempt at discontinuing TKI does not preclude a second successful attempt. Cancer 2017;123:4403-10. © 2017 American Cancer Society." @default.
• W2736720011 created "2017-07-31" @default.
• W2736720011 creator A5000074573 @default.
• W2736720011 creator A5004066423 @default.
• W2736720011 creator A5007283971 @default.
• W2736720011 creator A5036847941 @default.
• W2736720011 creator A5038427683 @default.
• W2736720011 creator A5043794507 @default.
• W2736720011 creator A5048325273 @default.
• W2736720011 creator A5051984074 @default.
• W2736720011 creator A5052564121 @default.
• W2736720011 creator A5055797334 @default.
• W2736720011 creator A5068342352 @default.
• W2736720011 creator A5070207000 @default.
• W2736720011 creator A5075844368 @default.
• W2736720011 creator A5077014294 @default.
• W2736720011 creator A5078121817 @default.
• W2736720011 creator A5082576550 @default.
• W2736720011 creator A5083553066 @default.
• W2736720011 date "2017-07-25" @default.
• W2736720011 modified "2023-10-05" @default.
• W2736720011 title "Second tyrosine kinase inhibitor discontinuation attempt in patients with chronic myeloid leukemia" @default.
• W2736720011 cites W1827459324 @default.
• W2736720011 cites W1975541563 @default.
• W2736720011 cites W1978349958 @default.
• W2736720011 cites W1987930421 @default.
• W2736720011 cites W2014316424 @default.
• W2736720011 cites W2018488520 @default.
• W2736720011 cites W2019633460 @default.
• W2736720011 cites W2036987278 @default.
• W2736720011 cites W2063410011 @default.
• W2736720011 cites W2064367288 @default.
• W2736720011 cites W2074301005 @default.
• W2736720011 cites W2077812841 @default.
• W2736720011 cites W2084397515 @default.
• W2736720011 cites W2090682224 @default.
• W2736720011 cites W2117356576 @default.
• W2736720011 cites W2122113546 @default.
• W2736720011 cites W2132053539 @default.
• W2736720011 cites W2151486690 @default.
• W2736720011 cites W2154856176 @default.
• W2736720011 cites W2189113171 @default.
• W2736720011 cites W2313607879 @default.
• W2736720011 cites W2322365534 @default.
• W2736720011 cites W2473480037 @default.
• W2736720011 cites W2528188718 @default.
• W2736720011 cites W2557854027 @default.
• W2736720011 cites W2560342075 @default.
• W2736720011 cites W2599933225 @default.
• W2736720011 doi "https://doi.org/10.1002/cncr.30885" @default.
• W2736720011 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28743166" @default.
• W2736720011 hasPublicationYear "2017" @default.
• W2736720011 type Work @default.
• W2736720011 sameAs 2736720011 @default.
• W2736720011 citedByCount "80" @default.
• W2736720011 countsByYear W27367200112017 @default.
• W2736720011 countsByYear W27367200112018 @default.
• W2736720011 countsByYear W27367200112019 @default.
• W2736720011 countsByYear W27367200112020 @default.
• W2736720011 countsByYear W27367200112021 @default.
• W2736720011 countsByYear W27367200112022 @default.
• W2736720011 countsByYear W27367200112023 @default.
• W2736720011 crossrefType "journal-article" @default.
• W2736720011 hasAuthorship W2736720011A5000074573 @default.
• W2736720011 hasAuthorship W2736720011A5004066423 @default.
• W2736720011 hasAuthorship W2736720011A5007283971 @default.
• W2736720011 hasAuthorship W2736720011A5036847941 @default.
• W2736720011 hasAuthorship W2736720011A5038427683 @default.
• W2736720011 hasAuthorship W2736720011A5043794507 @default.
• W2736720011 hasAuthorship W2736720011A5048325273 @default.
• W2736720011 hasAuthorship W2736720011A5051984074 @default.
• W2736720011 hasAuthorship W2736720011A5052564121 @default.
• W2736720011 hasAuthorship W2736720011A5055797334 @default.
• W2736720011 hasAuthorship W2736720011A5068342352 @default.
• W2736720011 hasAuthorship W2736720011A5070207000 @default.
• W2736720011 hasAuthorship W2736720011A5075844368 @default.
• W2736720011 hasAuthorship W2736720011A5077014294 @default.
• W2736720011 hasAuthorship W2736720011A5078121817 @default.
• W2736720011 hasAuthorship W2736720011A5082576550 @default.
• W2736720011 hasAuthorship W2736720011A5083553066 @default.
• W2736720011 hasBestOaLocation W27367200111 @default.
• W2736720011 hasConcept C121608353 @default.
• W2736720011 hasConcept C126322002 @default.
• W2736720011 hasConcept C143998085 @default.
• W2736720011 hasConcept C144301174 @default.
• W2736720011 hasConcept C2778715236 @default.
• W2736720011 hasConcept C2778729363 @default.
• W2736720011 hasConcept C2778820342 @default.
• W2736720011 hasConcept C38180746 @default.
• W2736720011 hasConcept C71924100 @default.
• W2736720011 hasConcept C90924648 @default.
• W2736720011 hasConceptScore W2736720011C121608353 @default.
• W2736720011 hasConceptScore W2736720011C126322002 @default.
• W2736720011 hasConceptScore W2736720011C143998085 @default.
• W2736720011 hasConceptScore W2736720011C144301174 @default.
• W2736720011 hasConceptScore W2736720011C2778715236 @default.
• W2736720011 hasConceptScore W2736720011C2778729363 @default.
• W2736720011 hasConceptScore W2736720011C2778820342 @default.

• next